Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Withdrawn 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other neoplasm 1Head & Neck 1

Conditions

Precancerous Conditions 6Uterine Cervical Neoplasms 3Uterine Cervical Dysplasia 2Malignant Neoplasms of Independent (Primary) Multiple Sites 2Small Cell Lung Carcinoma 1Recurrent respiratory papillomatosis 1Primary Condition: Advanced Tumors 1Papillomavirus Infections 1Neoplasms 1Neoplasm Metastasis 1Mesothelioma, Malignant 1Malignant Neoplasms of Female Genital Organs 1Malignant Neoplasms of Digestive Organs 1Malignant Neoplasms Stated as Primary Lymphoid Haematopoietic 1Malignant Neoplasm in the Head and Neck 1Lung Neoplasms 1Keratosis, Actinic 1Carcinoma, Non-Small-Cell Lung 1Breast Neoplasms 1Breast Cancer Female 1Advanced Malignant Neoplasm 1

Interventions

iodixanol 1Polyvinyl Alcohol 1Iodized Oil 1Ethiodized Oil 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Withdrawn × Malignant Neoplasm in the Head and Neck × Other neoplasm × Clear all
NCT05490381 2023-12-12

Preoperative Embolization of Hypervascular Head and Neck Tumors to Improve Surgical Outcomes

University of Washington

Phase 1 Withdrawn
Head & NeckOther neoplasm

Malignant Neoplasm in the Head and Neck

Data powered by HemOnc (CC BY 4.0) Colophon âš¡